Clinical Trial Diversity Plans: Early Oncology Experience Shows More Work Needed, US FDA Says

 
• By Sue Sutter
  
Wrench and bolt
Bolt-on approaches to making clinical trials more diverse are not effective, FDA's Peter Stein said. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D